市場概況

Endoscopes are medical devices that allow minimally invasive procedures by inserting them through natural body openings to observe internal organs or tissues in detail. These devices are commonly used for imaging and minor surgeries.

The Endoscopy Devices Market is projected to grow from USD 33,271 百万で 2022 米ドルへ 45,420 百万までに 2028, 年間複利成長率 (CAGR) の 6.56% 予測期間中 (2023-2028).

The increasing prevalence of chronic and other diseases is expected to drive the adoption of endoscopy for diagnostic and therapeutic purposes, thereby contributing to market growth. A study published by the British Heart Foundation (BHF) 1月に 2022 highlighted the global burden of cardiovascular diseases, such as coronary heart disease, peripheral arterial disease, stroke, and atrial fibrillation. The demand for endoscopy procedures for diagnostic purposes is likely to rise due to the high burden of cardiovascular diseases, further fueling market growth.

さらに, the growing importance and adoption of minimally invasive surgeries worldwide have led to a steady increase in the utilization of endoscopy devices for improved patient outcomes. Minimally invasive surgery (MIS) is preferred for many abdominal and pelvic surgeries due to its benefits, including reduced morbidity and faster recovery times. The increasing adoption of MIS will drive the use of endoscopy devices for surgical monitoring purposes, thereby boosting market growth.

さらに, manufacturers of endoscopy devices are increasingly focusing on technological advancements to develop advanced endoscopy systems, contributing to market growth. 例えば, FUJIFILM Healthcare launched a dual-channel endoscope approved by the United States Food and Drug Administration (FDA) for upper and lower gastrointestinal applications in November 2021. 六月に 2022, Getinge released an updated version of the ED-Flow automated endoscope reprocessor with enhanced digital connectivity and data management capabilities, offering improved uptime and increased productivity.

要約すれば, factors such as the high prevalence of chronic diseases, 技術の進歩, and product launches by market players are expected to drive significant growth in the global endoscopy devices market. しかし, challenges related to the lack of skilled technicians and infections caused by some endoscopes may hinder market growth.

市場セグメンテーション

市場はさまざまな要因に基づいて分割されます, including type of device, 応用, と地域.

Segmentation by Type of Device
Endoscopes – Rigid Endoscope, Flexible Endoscope, Capsule Endoscope, and Robot-assisted Endoscope – Irrigation/Suction System, Access Device, Wound Protector, Insufflation Device, Operative Manual Instrument, and Other Endoscopic Operative Devices
Visualization Equipment – Endoscopic Camera, SD Visualization System, and HD Visualization System

アプリケーションごとのセグメンテーション
Gastroenterology
Pulmonology
Orthopedic Surgery
Cardiology
ENT Surgery
Gynecology
神経内科
その他の用途

地域ごとのセグメンテーション
北米 – アメリカ, カナダ, そしてメキシコ
ヨーロッパ – イギリス, ドイツ, フランス, イタリア, スペイン, およびその他のヨーロッパ
アジア太平洋地域 – 中国, 日本, インド, 韓国, オーストラリア, およびその他のアジア太平洋地域
ラテンアメリカ – ブラジル, アルゼンチン, およびその他のラテンアメリカ諸国
中東とアフリカ – 南アフリカ, GCC, およびその他の中東およびアフリカ

In terms of device types, the endoscopes segment held the largest market share in 2022, amounting to USD 13,056 百万. It is projected to experience a compound annual growth rate (CAGR) の 6.71% 予測期間にわたって. Within the endoscope scopes category, flexible endoscopes accounted for the majority of the segment, 米ドルで 6,650 百万で 2022 and an expected CAGR of 5.86% 予測期間にわたって. A flexible endoscope is an optical instrument that transmits light and captures images for observation. These instruments are equipped with flexible transparent fibers. The flexible endoscope segment is anticipated to grow during the forecast period due to its advantages over other alternatives, increasing launches, and higher adoption rates.

The extensive use of endoscopes is necessary for diagnosing various chronic diseases such as inflammatory bowel diseases (IBD), stomach cancer, colon cancer, respiratory infections, respiratory tumors, もっと. その結果, the high prevalence of these diseases leads to a surge in demand for flexible endoscopes. 例えば, according to the American Cancer Society’s 2023 報告, there were an estimated 26,380 new cases of stomach cancer diagnosed in the United States in 2022, with an estimated 26,500 new cases projected for 2023. したがって, the high incidence and prevalence of such chronic diseases drive the demand for flexible endoscopes. さらに, the launch of new products and approvals by market players are expected to propel the growth of the flexible endoscope segment. An example of this is Boston Scientific receiving FDA approval for the EXALT Model B Single-Use Bronchoscope in August 2021. This bronchoscope is specifically designed for complex respiratory procedures in the ICU. その結果, significant growth is expected in the flexible endoscope segment due to the increasing prevalence of diseases, the advantages offered by flexible endoscopes, and continuous product launches.

アプリケーションに関しては, the gastroenterology segment held the largest market share in 2022, amounting to USD 7,486 百万, and it is expected to witness a CAGR of 5.16% 予測期間にわたって. Gastrointestinal endoscopy involves the use of a long, フレキシブル, lighted instrument called an endoscope to examine the digestive system by inserting it either through the rectum or down through the throat. This procedure is used to evaluate and treat disorders of the esophagus, stomach, small intestine, colon, pancreas, and bile ducts. The growth of the gastroenterology segment is primarily driven by the increasing incidence of gastrointestinal diseases across all age groups. Examples of such disorders include dyspepsia, irritable bowel syndrome, and constipation. Gastroesophageal reflux disease is also a prevalent type of organic gastrointestinal disorder. The growing burden of gastrointestinal diseases, coupled with the aging population, fuels the demand for gastrointestinal endoscopy. Gastrointestinal tumors are the second leading cause of cancer-related deaths globally, and endoscopy has become the standard method for diagnosing gastrointestinal cancers. その結果, the increasing number of endoscopic procedures for early cancer detection is expected to boost the market in the coming years, particularly for gastrointestinal stromal tumors originating in the rectum, colon, and esophagus.

地理的に, North America dominated the market in 2022, with a market share of USD 12,785 百万, and it is projected to grow at a CAGR of 6.45% 予測期間にわたって. The region’s endoscopy market is driven by the high burden of diseases such as cardiovascular diseases, colorectal cancer, stomach cancer, and the increasing adoption of minimally invasive surgeries. Technological innovations, approvals, 製品の発売, and partnerships by market players also contribute to the market’s growth. 例えば, according to data from Cedars-Sinai updated in January 2022, coronary artery bypass graft surgery (CABG) is the most common heart surgery in the United States, オーバーで 300 thousand successful procedures performed each year. This high number of bypass surgeries may lead to increased demand for image-guided surgical systems, thereby driving the growth of endoscopy devices in the country.

さらに, the market in North America is expected to be boosted by an increase in endoscopic procedures for early diagnosis of gastrointestinal and colorectal cancers. As per the American Cancer Society’s 2023 報告, there are expected to be approximately 21.5 thousand diagnosed cases of esophagus cancer, 26.5 thousand cases of stomach cancer, と 153 thousand cases of colorectal cancer in the United States in 2023. The high burden of these cancers will drive the demand for endoscopy devices in the country during the forecast period.

The region also experiences significant growth due to the continuous launches and approvals of endoscopy devices. 例えば, Zsquare, a developer of single-use endoscopes, received FDA 510K clearance in July 2022 to market its product, the Zsquare ENT-Flex Rhinolaryngoscope, in the United States. さらに, PENTAX Medical launched the Performance Endoscopic Ultrasound (EUS) system in Canada in November 2022. PENTAX Medical is a leading healthcare industry player in diagnostic and therapeutic endoscopy solutions.

したがって, factors such as increasing product launches, the adoption of minimally invasive imaging and surgeries for chronic diseases, and technological advancements are expected to drive the growth of the endoscopy market in Canada during the forecast period.

競争環境

The market exhibits a moderate level of competition and is populated by several prominent global players. These companies strive to establish clear differentiation in their endoscopic systems based on their specific applications. The key market players include Boston Scientific Corporation, Medtronic PLC, Olympus Corporation, クック グループ インコーポレーテッド, and Johnson & ジョンソン.

Key companies profiled in this report include Boston Scientific Corporation, Conmed Corporation, クック グループ インコーポレーテッド, Richard Wolf GmbH, ジョンソン & ジョンソン, Fujifilm Holdings Corporation, Medtronic PLC, Olympus Corporation, Karl Storz SE & コ. KG, ストライカーコーポレーション.

最近の業界の発展

1月に 2023, AA Medical announced a strategic partnership with Certified Endoscopy Products, a reputable medical device reprocessing company based in Chicago, with expertise in endoscopic devices. Together, AA Medical and Certified Endoscopy will establish a leading medical device reprocessing company that will cater to the needs of the endoscopy, orthopedic, and other surgical device markets.

8月に 2022, Medtronic introduced GI Genius, an innovative artificial intelligence module for endoscopy procedures aimed at addressing colorectal cancer in India. This advanced medical solution provides real-time data and empowers physicians with enhanced visualization during colonoscopy, enabling them to detect and treat colorectal cancer more effectively. The introduction of GI Genius represents a significant step forward in improving outcomes for patients with colorectal cancer through cutting-edge technology and augmented capabilities for physicians.

主な質問への回答

What is the duration of the study period for the Global Endoscopy Devices Market?
The Global Endoscopy Devices Market has been studied from 2018 に 2028.

What is the growth rate of the Global Endoscopy Devices Market?
The Global Endoscopy Devices Market is experiencing a compound annual growth rate (CAGR) の 6.56% 今後5年間にわたって.

What is the size of the Global Endoscopy Devices Market?
The Global Endoscopy Devices Market is projected to reach USD 33,271 百万で 2022 そして、CAGR で成長すると予想されます。 6.56% 米ドルに到達するには 45,420 百万までに 2028.

Which region exhibits the highest growth rate in the Global Endoscopy Devices Market?
The Asia Pacific region demonstrates the highest CAGR between 2018 と 2028 in the Global Endoscopy Devices Market.

Which region holds the largest share in the Global Endoscopy Devices Market?
の 2022, North America holds the highest market share in the Global Endoscopy Devices Market.

Who are the key players operating in the Global Endoscopy Devices Market?
The major companies operating in the Global Endoscopy Devices Market include Medtronic PLC, Olympus Corporation, クック グループ インコーポレーテッド, ジョンソン & ジョンソン, and Boston Scientific Corporation.